Combining Senolytics and Stem Cells Shows Promise in Mice

A new study associated with Immorta Bio suggests that combining a senolytic vaccine with mesenchymal stem cells might create a synergistic impact. However, the findings rest on acute, artificially induced injury models rather […]

This story was reported by Lifespan Research Institute. EUROPES curates Europe's most relevant coverage — read the full report at the original source.